Clinical Trial Detail

NCT ID NCT03136406
Title QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors NantCell, Inc.
Indications

pancreatic cancer

Therapies

GI-4000

Leucovorin

Avelumab

Nab-paclitaxel

Bevacizumab

Cyclophosphamide

Capecitabine

Oxaliplatin

Fluorouracil

ETBX-011

ALT-803

Age Groups: adult senior

No variant requirements are available.